Work is underway to introduce the drug in tablet form into the spinal muscular atrophy (SMA) treatment program. "For me, as a person who looks at systemic solutions, it is natural that when another therapeutic option comes along that can benefit both patients and the system, we integrate it into...
The attempt to increase outlays for drug programs at the expense of funds earmarked for drugs for seniors is not only an injustice to one group of patients, but also a sabotage of the Polish economy and Poland's drug security, the National Drug Manufacturers alert.
In Subcarpathia, sanepid has recorded more than ten cases of measles, and an epidemiological investigation is underway. We should not be surprised, because the level of immunization against the disease is far from the recommended 95 percent.
On Monday, December 1, the next meeting of the Transparency Council.
We talk about the model treatment of SMA and the future of spinal muscular atrophy treatment with Prof. Katarzyna Kotulska-Jóźwiak from the Department of Neurology and Epileptology at the Children's Memorial Health Institute.
Officers of the Central Bureau for Combating Cybercrime have detained seven more people suspected of involvement in a criminal group producing and selling counterfeit medicinal products on the Internet - including fake hormonal drugs, anabolic steroids and preparations requiring a prescription....
Poland reports very well on HPV prevention, we have modern secondary prevention and a good vaccination program. The problem is low enrollment in preventive examinations and a low percentage of vaccinated children and adolescents, according to a report presented to the Senate on Monday.
The Opole-based National Tax Administration has detected serious irregularities in the CIT settlements of an international pharmaceutical company. After the audit, the company corrected its declarations and paid more than PLN 11.5 million in outstanding tax with interest.
In the case of breast cancer, the indirect costs resulting from the abandonment of work, disability and the need for home care for the patient are most often several times higher than the NHF's expenditure on treatment. Therefore, the cost of an innovation should not be considered only in terms...
The problem of shortages, or temporary lack of access to medicines, affects patients in all countries of the European Union, and we know about it not only from the message of physician colleagues working in various European countries, but also from data collected by the EMA, explains Professor...
Patients and the expert community are waiting for a decision that could make life with the disease easier for many patients. In October, the President of the Agency for Health Technology Assessment and Tarification issued a positive recommendation to include the tablet form of the drug for the...
Drug programs enable patients to benefit from expensive and innovative drugs. Those who have access to such treatment because they qualify for the program appreciate this fact, although they also point out the drawbacks that accompany this treatment formula. However, the main problem for patients...
The Chief Pharmaceutical Inspector has recalled a batch of an anticoagulant drug from circulation nationwide.
On Monday, November 17, the next meeting of the Transparency Council.
A program to treat spinal muscular atrophy (SMA) with nusinersen has been in place in Poland for seven years. Observational studies show that patients, including those with advanced disease, benefit in real ways - not only stabilization, but also gradual improvement in function. The Polish...
Diffuse large B-cell lymphoma (DLBCL) is the most common and one of the most aggressive lymphomas, which can progress rapidly and produce a variety of often confusing symptoms. Nevertheless, as Prof. Jan Maciej Zaucha, head of the Department of Hematology, Transplantation and Cellular Therapies...
The Chief Pharmaceutical Inspector has decided to immediately recall a batch of a drug used to treat thyroid disease.
Wednesday, November 12, the next meeting of the Transparency Council.
Although hemophilia care in Poland is one of the best organized among rare diseases, two new reports - from the Institute for Healthcare Management at Lazarski University and EconMed Europe - show that in addition to good access to drug therapies, there is a growing need to strengthen coordinated...
On Monday, November 3, the next meeting of the Transparency Council.
The Ministry of Health reminds that antiretroviral treatment in Poland is fully funded under the Government Health Policy Program and available to all people living with HIV - regardless of their health insurance or citizenship.
Polish women eligible for free mammography under the National Health Service expect systemic solutions that will increase the sense of security and quality of breast cancer treatment - especially coordination of oncology care, the ability to get a "second opinion," and access to multi-gene...
On Monday, October 27, the next meeting of the AOTMiT Transparency Council.
A Notice of the Minister of Health dated October 22, 2025 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland has been published in the Official Journal of the Ministry of...
Poland's drug production is growing - as of 2019, it has increased by 45%, or an average of almost 8% year-on-year. The pharmaceutical sector's long-term contribution to GDP is relatively constant, indicating an industry growth rate comparable to that of the economy as a whole. - However, the...
On Monday, October 20, the next meeting of the Transparency Council.
Polskie Towarzystwo Reumatologiczne pozytywnie ocenia decyzję Ministra Zdrowia o ponownym wprowadzeniu refundacji drugiego leku biopodobnego zawierającego etanercept. Zgodnie z obwieszczeniem z 17 września 2025 r., od 1 października refundowany będzie preparat Nepexto 50 mg dla pacjentów...
On Monday, October 13, the next meeting of the Transparency Council.
On Monday, October 6, the next meeting of the Transparency Council.
Modern therapies in hemophilia mean not only more effective prevention of bleeding, but also a real improvement in patients' quality of life. We talk about the possibilities of modern bleeding prevention and the need for access to various therapies with Professor Wojciech Mlynarski, president of...
© 2023 Medexpress. All Rights Reserved
